Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Vitiligo

Vitiligo or leukoderma is a chronic skin condition that causes loss of pigment, resulting in irregular pale patches of skin. The precise cause of vitiligo is complex and not fully understood. There is some evidence suggesting it is caused by a combination of auto-immune, genetic, and environmental factors. The population incidence worldwide is considered to be between 1% and 2% .According to Diseases Database:"A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached." (From the Wikpedia article Vitiligo.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Vitiligo:

Pubmed Logo
Nonmelanoma skin cancer in vitiligo patients.
ABSTRACT: The finding that molt-inhibiting hormone (MIH) regulates...
21st November, 2009
Department of Dermatology, Boonshoft School of Medicine, Wright State J Am Acad Dermatol. 2009 Dec;61(6):1080-1081.
DOI Direct Link
Estimation of cost-of-illness in patients with psoriasis in Switzerland.
BACKGROUND: Evaluation of the current clinical treatment of psoriasis in...
20th November, 2009
Department of Dermatology, University of Zurich, Zurich, Switzerland. Swiss Med Wkly. 2009 Nov 19.
DOI Direct Link
Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders.
Meta-analysis of genomic coordinates of SNP variations identified in...
20th November, 2009
Translational and Functional Genomics Laboratory, Department of Pathology Cell Cycle. 2009 Dec 17;8(23).
Down's syndrome with lichen nitidus and segmental vitiligo.
Meta-analysis of genomic coordinates of SNP variations identified in...
17th November, 2009
Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):627-9.
DOI Direct Link
Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilial vitiligo.
BACKGROUND: Various studies worldwide suggest that human leukocyte antigen...
17th November, 2009
Department of Dermatology, Seth G S Medical College and KEM Hospital, Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):583-7.
DOI Direct Link

View more research publications.

Press Releases About Vitiligo:

BioPortfolio Logo
SWITCH Biotech AG Joint Forces Against Vitiligo 1st November, 2003 Switch
SWITCH Biotech AG Joint Forces Against Vitiligo Development Co-operation Agreement Signed With Spirig Pharma for Vitiligo Product Neuried (March 30, 2004) - SWITCH Biotech AG, a

BioNews Results for Vitiligo:

RSS Logo
BioPortfolio Logo
Vitiligo Therapy: Research data from A. Fongers and colleagues update understanding of vitiligo therapy
NewsRX:  Nov 21 2009 5:47AM Matching: vitiligo
Vitiligo and the melanocyte reservoir
MDLinx:  Nov 19 2009 10:59AM Matching: vitiligo
Vitiligo treatment with vitamins, minerals and polyphenol supplementation
MDLinx:  Nov 13 2009 11:06AM Matching: vitiligo
Genome-Wide Association Study of Generalized Vitiligo in an Isolated European Founder Population Identifies SMOC2, in Close Proximity to IDDM8
Journal of Investigative Dermatology:  Nov 5 2009 1:14PM Matching: vitiligo
PhotoMedex Appoints Christina L. Allgeier Chief Financial Officer
SmartBrief:  Nov 5 2009 8:42PM Matching: vitiligo
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Vitiligo Patents:

USPTO Logo
US Patent No.Title
7572808 Triazolopyridine cannabinoid receptor 1 antagonists
7582314 Compositions and methods for the management of hyperproliferative dermatological conditions
7582609 Method for the treatment of skin fibrosis and suitable compositions for such treatment
7582631 Substituted heterocyclic compounds and methods of use
7582657 Vanilloid receptor ligands and their use in treatments

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Vitiligo scientists - we have details of around 339 individuals working on Vitiligo .


This page has been viewed 1282 times
Recent Search Terms used to find this page: vitiligo lijek | bioportofolio vitiligo | Vitiligo what general physicians need to know | vitiligo treatment in iran tehran video | Vitiligo lijek | switch biotech vitiligo | vitiligo bioportofolio 2009 | vitiligo lijek | vitiligo lijek | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Vitiligo across BioPortfolio, or for Vitiligo Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.